ASLAN Pharmaceuticals

Investor Relations

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-037123.pdf
0001564590-19-037123.rtf
0001564590-19-037123.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-036514.pdf
0001564590-19-036514.rtf
0001564590-19-036514.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-035986.pdf
0001564590-19-035986.rtf
0001564590-19-035986.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-033234.pdf
0001564590-19-033234.rtf
0001564590-19-033234.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-031981.pdf
0001564590-19-031981.rtf
0001564590-19-031981.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-026442.pdf
0001564590-19-026442.rtf
0001564590-19-026442.xls
RW

Withdrawal of registration statement filed under the Securities Act
Other
 View HTML
0001193125-19-186061.pdf
0001193125-19-186061.rtf
0001193125-19-186061.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-023547.pdf
0001564590-19-023547.rtf
0001564590-19-023547.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-19-023548.pdf
0001564590-19-023548.rtf
0001564590-19-023548.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001193125-19-174310.pdf
0001193125-19-174310.rtf
0001193125-19-174310.xls